These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3904070)

  • 41. Phenelzine vs placebo in 50 patients with bulimia.
    Walsh BT; Gladis M; Roose SP; Stewart JW; Stetner F; Glassman AH
    Arch Gen Psychiatry; 1988 May; 45(5):471-5. PubMed ID: 3282482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coadministration of phenelzine and methylphenidate for treatment-resistant depression.
    Shelton Clauson A; Elliott ES; Watson BD; Treacy J
    Ann Pharmacother; 2004 Mar; 38(3):508. PubMed ID: 14970373
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy of phenelzine in geriatric depression.
    Lazarus LW; Groves L; Gierl B; Pandey G; Javaid JI; Lesser J; Ha YS; Davis J
    Biol Psychiatry; 1986 Jun; 21(7):699-701. PubMed ID: 3708040
    [No Abstract]   [Full Text] [Related]  

  • 44. [Monoamine oxidase inhibitors: various clinical remarks on phenelzine].
    Guyotat J; Favre-Tissot M; Marie-Cardine M
    J Med Lyon; 1966 Jun; 47(101):1009-15. PubMed ID: 4914860
    [No Abstract]   [Full Text] [Related]  

  • 45. Acute psychosis following phenelzine discontinuation.
    Liskin B; Roose SP; Walsh BT; Jackson WK
    J Clin Psychopharmacol; 1985 Feb; 5(1):46-7. PubMed ID: 3973072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Blood platelet MAO activity in endogenous depressive syndrome].
    Puzyński S; Hauptmann M; Załuska M
    Psychiatr Pol; 1980; 14(6):575-80. PubMed ID: 7232599
    [No Abstract]   [Full Text] [Related]  

  • 47. Monoamine oxidase inhibitors for depressed cardiac patients.
    Lippmann SB; Manshadi MS; Gultekin A
    J Clin Psychiatry; 1985 Dec; 46(12):545-6. PubMed ID: 4066625
    [No Abstract]   [Full Text] [Related]  

  • 48. The effect of isocarboxazid on platelet MAO activity.
    Davidson J; White H
    Biol Psychiatry; 1983 Sep; 18(9):1075-9. PubMed ID: 6640004
    [No Abstract]   [Full Text] [Related]  

  • 49. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y; Karniel E; Szor H
    Isr J Psychiatry Relat Sci; 1996; 33(3):211-2. PubMed ID: 9009521
    [No Abstract]   [Full Text] [Related]  

  • 50. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan.
    Pope HG; Jonas JM; Hudson JI; Kafka MP
    Am J Psychiatry; 1985 Apr; 142(4):491-2. PubMed ID: 3976924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phenelzine treatment of depression with chronic diarrhea.
    Weiss KJ; Schwartz HJ; Berrettini WH
    J Clin Psychiatry; 1982 Jun; 43(6):250-1. PubMed ID: 7085581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phenelzine use throughout pregnancy and the puerperium: case report, review of the literature, and management recommendations.
    Gracious BL; Wisner KL
    Depress Anxiety; 1997; 6(3):124-8. PubMed ID: 9442987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monoamine oxidase inhibitor-induced speech blockage.
    Goldstein DM; Goldberg RL
    J Clin Psychiatry; 1986 Dec; 47(12):604. PubMed ID: 3782047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relationship of acetylation phenotype to treatment with MAOIs: a review.
    Rose S
    J Clin Psychopharmacol; 1982 Jun; 2(3):161-4. PubMed ID: 7096607
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of monoamine oxidase substrate activities in twins, schizophrenics, depressives, and controls.
    Nies A; Robinson DS; Harris LS; Lamborn KR
    Adv Biochem Psychopharmacol; 1974; 12(0):59-70. PubMed ID: 4607593
    [No Abstract]   [Full Text] [Related]  

  • 58. Antidepressant treatment of bulimia: preliminary experience and practical recommendations.
    Pope HG; Hudson JI; Jonas JM
    J Clin Psychopharmacol; 1983 Oct; 3(5):274-81. PubMed ID: 6355206
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Preliminary study on platelet monoamine oxidase in schizophrenic patients].
    Huang MS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1980 Apr; 13(4):193-6. PubMed ID: 7261730
    [No Abstract]   [Full Text] [Related]  

  • 60. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.